Curanex Pharmaceuticals Inc (CURX)

$4.19 -0.10 (-2.33%)
Market Cap 6.73M
Revenue (ttm) 0.00
Net Income (ttm) -4.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,500
Avg Vol 16,984
Day's Range N/A - N/A
Shares Out 1.57M
Stochastic %K 14%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was fou...

Industry: Biotechnology
Sector: Healthcare
Phone: 718 673 6078
Address:
2 Jericho Plaza, Suite 101B, Jericho, United States
stardusterr
stardusterr Sep. 15 at 6:50 PM
$CURX does anybody really like this stock?
1 · Reply
Yingtrader7
Yingtrader7 Sep. 15 at 3:17 PM
$CURX hello anybody home
0 · Reply
Austinx
Austinx Sep. 14 at 7:21 PM
$CURX Buying in this zone
0 · Reply
RhythmGuitar1
RhythmGuitar1 Sep. 11 at 1:55 PM
$CURX we’re bringing it back we’re bringing it back we’re bringing it back we’re bringing it back !
0 · Reply
Trademain
Trademain Sep. 10 at 4:21 PM
$CURX
0 · Reply
Bitbuy604
Bitbuy604 Sep. 10 at 2:05 PM
$CURX holding. This will go one day
0 · Reply
Austinx
Austinx Sep. 9 at 4:11 PM
$CURX Back to 3.60s? This should fly with volume
0 · Reply
Yingtrader7
Yingtrader7 Sep. 9 at 2:50 PM
$CURX SCAMMED,
0 · Reply
Marvocado87
Marvocado87 Sep. 9 at 2:35 PM
$CURX
0 · Reply
Gmoney2020
Gmoney2020 Sep. 9 at 2:22 PM
$CURX i’m going insane. This is so boring
1 · Reply
Latest News on CURX
Curanex Pharmaceuticals Inc trading halted, news pending

2026-08-19T23:50:10.000Z - 4 weeks ago

Curanex Pharmaceuticals Inc trading halted, news pending

Curanex Pharmaceuticals Quarterly report: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 4 weeks ago

Curanex Pharmaceuticals Quarterly report: Q2 2026

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

May 14, 2026, 8:53 AM EDT - 4 months ago

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Apr 8, 2026, 7:47 AM EDT - 5 months ago

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Curanex highlights patient case study in treatment of cancer cachexia

2026-04-06T13:58:25.000Z - 5 months ago

Curanex highlights patient case study in treatment of cancer cachexia

Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care

Apr 6, 2026, 9:17 AM EDT - 5 months ago

Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company

Apr 2, 2026, 8:07 AM EDT - 5 months ago

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission

Mar 30, 2026, 5:35 PM EDT - 5 months ago

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission

Curanex completes dose-range finding toxicology study of Phyto-N

2026-03-18T12:17:58.000Z - 6 months ago

Curanex completes dose-range finding toxicology study of Phyto-N

Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission

Mar 18, 2026, 8:00 AM EDT - 6 months ago

Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers

Mar 12, 2026, 9:30 AM EDT - 6 months ago

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers

Curanex appoints two research experts to board of directors

2026-03-11T12:23:14.000Z - 6 months ago

Curanex appoints two research experts to board of directors

BMY

Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board

Mar 11, 2026, 8:00 AM EDT - 6 months ago

Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board

Curanex announces formation of Scientific Advisory Board

2026-03-05T13:25:48.000Z - 6 months ago

Curanex announces formation of Scientific Advisory Board

Curanex Forms World Class Scientific Advisory Board

Mar 5, 2026, 8:00 AM EST - 6 months ago

Curanex Forms World Class Scientific Advisory Board

Curanex provides operational update on regulatory milestones

2026-02-25T13:17:16.000Z - 6 months ago

Curanex provides operational update on regulatory milestones

Curanex Provides Operational Update on Key Regulatory Milestones

Feb 25, 2026, 8:00 AM EST - 6 months ago

Curanex Provides Operational Update on Key Regulatory Milestones

Curanex engages Strategic Investor Relations to enhance Curanex’s visibility

2025-10-22T11:15:34.000Z - 10 months ago

Curanex engages Strategic Investor Relations to enhance Curanex’s visibility

Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement

Oct 22, 2025, 7:00 AM EDT - 10 months ago

Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement

Curanex Pharmaceuticals Inc trading resumes

2025-09-17T15:35:16.000Z - 12 months ago

Curanex Pharmaceuticals Inc trading resumes

Curanex Pharmaceuticals Inc trading halted, volatility trading pause

2025-09-17T15:20:18.000Z - 12 months ago

Curanex Pharmaceuticals Inc trading halted, volatility trading pause

Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters

Sep 12, 2025, 2:46 PM EDT - 1 year ago

Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters

Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering

Aug 27, 2025, 5:00 PM EDT - 1 year ago

Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering

Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering

Aug 26, 2025, 7:30 AM EDT - 1 year ago

Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering

stardusterr
stardusterr Sep. 15 at 6:50 PM
$CURX does anybody really like this stock?
1 · Reply
Yingtrader7
Yingtrader7 Sep. 15 at 3:17 PM
$CURX hello anybody home
0 · Reply
Austinx
Austinx Sep. 14 at 7:21 PM
$CURX Buying in this zone
0 · Reply
RhythmGuitar1
RhythmGuitar1 Sep. 11 at 1:55 PM
$CURX we’re bringing it back we’re bringing it back we’re bringing it back we’re bringing it back !
0 · Reply
Trademain
Trademain Sep. 10 at 4:21 PM
$CURX
0 · Reply
Bitbuy604
Bitbuy604 Sep. 10 at 2:05 PM
$CURX holding. This will go one day
0 · Reply
Austinx
Austinx Sep. 9 at 4:11 PM
$CURX Back to 3.60s? This should fly with volume
0 · Reply
Yingtrader7
Yingtrader7 Sep. 9 at 2:50 PM
$CURX SCAMMED,
0 · Reply
Marvocado87
Marvocado87 Sep. 9 at 2:35 PM
$CURX
0 · Reply
Gmoney2020
Gmoney2020 Sep. 9 at 2:22 PM
$CURX i’m going insane. This is so boring
1 · Reply
Bitbuy604
Bitbuy604 Sep. 9 at 2:01 PM
$CURX we need more volume
0 · Reply
RhythmGuitar1
RhythmGuitar1 Sep. 9 at 2:00 PM
$CURX TRAP DOOR FORCES ARE IN PLACE. THE BASTARDIZED REAL NEWS
0 · Reply
Gmoney2020
Gmoney2020 Sep. 9 at 1:59 PM
$CURX my only pos
1 · Reply
Gmoney2020
Gmoney2020 Sep. 9 at 1:47 PM
$CURX there’s no volume so when people try to hurry up and get out the money manager forces it way low your money is essentially trapped. This is getting jerked all kinds of around with low volume.
0 · Reply
rob70
rob70 Sep. 9 at 1:39 PM
$CURX garbage
0 · Reply
Gmoney2020
Gmoney2020 Sep. 9 at 1:07 PM
$CURX no volume
0 · Reply
RhythmGuitar1
RhythmGuitar1 Sep. 9 at 11:37 AM
$CURX
0 · Reply
89gt
89gt Sep. 9 at 4:12 AM
$CURX back to the IPO price of $80 do it!
2 · Reply
Heb1972
Heb1972 Sep. 9 at 1:17 AM
$BCRX $PHAT $CURX CURX 500k float just passing along from another poster🤙 in with some skin here as well🫡
0 · Reply
Heb1972
Heb1972 Sep. 9 at 12:55 AM
$TLRY $CURX 🧐🤫🫡🤙
0 · Reply
mterrell
mterrell Sep. 9 at 12:48 AM
$CURX back at 5.80 over night round 2 tomorrow
2 · Reply
Gmoney2020
Gmoney2020 Sep. 8 at 11:26 PM
$CURX better wake up to $10 you low flosted slug lol
0 · Reply